Johnson & Johnson Stocks Jump 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September

The pharmaceutical company has signed an agreement with the US government's Biomedical Advanced Research and Development Authority to invest $1 billion in the effort, it said in a statement on Monday.

from Top Business News- News18.com https://ift.tt/2UzwCo1

• Tweet
• Share
• Share
• Share
• Share